HRGN · Harvard Apparatus Regenerative Technology, Inc. · Exempt Offerings
$2.19
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because these resources are not expected to fund the Company's operations for at least 12 months from the date the financial statements are issued, substantial doubt exists about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$34.63M
Shares
17.58M
Volume · Oct 2
1215
Avg daily vol (3M)
2381
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-09-14 | New | Biotechnology | $3,000,000 | $2,838,911 | 06b |
| 2026-01-06 | New | Biotechnology | $2,000,000 | $700,000 | 06b |
| 2025-07-14 | New | Biotechnology | $2,000,000 | $2,000,000 | 06b |
| 2024-08-06 | New | Biotechnology | $1,482,100 | $1,482,100 | 06b |
| 2023-04-14 | New | Biotechnology | $6,005,800 | $6,005,800 | 06b |
| 2022-06-08 | New | Biotechnology | $5,060,240 | $5,060,240 | 06b |
| 2021-09-10 | Amendment | Biotechnology | $3,000,000 | $2,600,000 | 06b |
| 2021-06-23 | New | Biotechnology | $2,000,000 | $600,000 | 06b |
| 2020-08-31 | New | Biotechnology | $6,892,163 | $500,000 | 06b |
| 2020-04-23 | New | Biotechnology | $2,177,502 | $2,177,502 | 06b |
Showing 1–10 of 10 filings